Severe disease during secondary dengue is thought in many cases to be associated with antibody‐dependent enhancement (ADE), where poorly neutralizing Abs specific to the previous DENV serotype facilitate infection into FcγR bearing immune cells and thereby facilitate infection [17, 18]. The gene discussed is FCGR2A; the disease is infection.